Mona L. Martin

1.5k total citations
43 papers, 1.1k citations indexed

About

Mona L. Martin is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Oncology. According to data from OpenAlex, Mona L. Martin has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Mona L. Martin's work include Asthma and respiratory diseases (4 papers), Eosinophilic Esophagitis (3 papers) and Pelvic floor disorders treatments (3 papers). Mona L. Martin is often cited by papers focused on Asthma and respiratory diseases (4 papers), Eosinophilic Esophagitis (3 papers) and Pelvic floor disorders treatments (3 papers). Mona L. Martin collaborates with scholars based in United States, United Kingdom and Germany. Mona L. Martin's co-authors include Donald L. Patrick, Tamara Bavendam, Todd H. Wagner, Donald M. Bushnell, Bhash Parasuraman, Kelly P. McCarrier, Shravanthi R. Gandra, Eldrin F. Lewis, Antonia V. Bennett and Margaret C. Reilly and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pain.

In The Last Decade

Mona L. Martin

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona L. Martin United States 15 408 253 248 185 112 43 1.1k
Gerhardt Pohl United States 16 201 0.5× 82 0.3× 170 0.7× 179 1.0× 78 0.7× 43 1.3k
Erkki Kujansuu Finland 26 451 1.1× 164 0.6× 476 1.9× 158 0.9× 104 0.9× 77 2.3k
Michael Schembri United States 19 256 0.6× 129 0.5× 327 1.3× 141 0.8× 143 1.3× 49 1.6k
Julie Krop United States 13 158 0.4× 48 0.2× 145 0.6× 163 0.9× 103 0.9× 33 1.2k
Anne M. Suskind United States 25 998 2.4× 927 3.7× 507 2.0× 436 2.4× 70 0.6× 95 1.8k
Stergios K. Doumouchtsis United Kingdom 26 970 2.4× 416 1.6× 793 3.2× 208 1.1× 61 0.5× 123 2.2k
Julie Birt United States 22 455 1.1× 64 0.3× 92 0.4× 50 0.3× 83 0.7× 61 1.2k
Marijke Van Kampen Belgium 26 607 1.5× 506 2.0× 724 2.9× 129 0.7× 54 0.5× 49 2.0k
Karen J. Carlson United States 15 164 0.4× 55 0.2× 237 1.0× 157 0.8× 103 0.9× 24 1.6k
Jemma Hudson United Kingdom 14 221 0.5× 44 0.2× 397 1.6× 104 0.6× 94 0.8× 55 1.2k

Countries citing papers authored by Mona L. Martin

Since Specialization
Citations

This map shows the geographic impact of Mona L. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona L. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona L. Martin more than expected).

Fields of papers citing papers by Mona L. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona L. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona L. Martin. The network helps show where Mona L. Martin may publish in the future.

Co-authorship network of co-authors of Mona L. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Mona L. Martin. A scholar is included among the top collaborators of Mona L. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona L. Martin. Mona L. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Mona L., et al.. (2024). Evaluating the User-Perceived Benefit of a Virtual Lung Cancer Patient Education and Support Community: LVNG With Lung Cancer. Journal of the Advanced Practitioner in Oncology. 15(5). 1–17.
2.
Martin, Mona L., et al.. (2021). How patients being treated for non-small cell lung cancer value treatment benefit despite side effects. Quality of Life Research. 31(1). 135–146. 3 indexed citations
3.
Polonsky, William H., et al.. (2021). Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study. Diabetes Spectrum. 34(2). 175–183. 12 indexed citations
4.
Hwang, Mark C., et al.. (2020). Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study. Quality of Life Research. 29(11). 3155–3166. 4 indexed citations
5.
Ma, Christopher, et al.. (2018). Physicians’ Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn’s Disease. Digestive Diseases and Sciences. 63(10). 2555–2563. 9 indexed citations
6.
Bushnell, Donald M., Steven I. Blum, Hiltrud Liedgens, et al.. (2018). Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2—The Patient Assessment for Low Back Pain–Impacts (PAL-I). Pain. 159(10). 2066–2075. 7 indexed citations
7.
Weitman, Evan, Matthew Perez, John F. Thompson, et al.. (2017). Quality of life patient-reported outcomes for locally advanced cutaneous melanoma. Melanoma Research. 28(2). 134–142. 14 indexed citations
8.
Rydén, Anna, Fiona Blackhall, Hye Ryun Kim, et al.. (2017). Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy. Patient. 10(5). 593–603. 9 indexed citations
9.
Globe, Gary, Ingela Wiklund, Wen‐Hung Chen, et al.. (2015). Psychometric Properties of the Asthma Symptom Diary (ASD), a Diary for Use in Clinical Trials of Persistent Asthma. The Journal of Allergy and Clinical Immunology In Practice. 4(1). 60–66.e4. 16 indexed citations
10.
11.
Martin, Mona L., et al.. (2012). Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient. International Journal of Clinical Practice. 66(9). 883–890. 12 indexed citations
12.
Martin, Mona L., Donald L. Patrick, Shravanthi R. Gandra, et al.. (2010). Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia. Quality of Life Research. 20(6). 889–901. 17 indexed citations
13.
Bushnell, Donald M., Mona L. Martin, Keith A. Moore, et al.. (2010). Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Current Medical Research and Opinion. 26(12). 2745–2755. 44 indexed citations
14.
Martin, Mona L., Donald L. Patrick, Donald M. Bushnell, Shravanthi R. Gandra, & Kim Gilchrist. (2008). Further Validation of an Individualized Migraine Treatment Satisfaction Measure. Value in Health. 11(5). 904–912. 10 indexed citations
15.
16.
Patrick, Donald L., et al.. (2003). Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings. Clinical Therapeutics. 25(11). 2920–2935. 24 indexed citations
17.
Bushnell, Donald M., Mona L. Martin, & Bhash Parasuraman. (2003). Electronic Versus Paper Questionnaires: A Further Comparison in Persons with Asthma. Journal of Asthma. 40(7). 751–762. 75 indexed citations
18.
Malmgren, Judith A., Mona L. Martin, & Ray M. Nicola. (1996). Health care access of poverty-level older adults in subsidized public housing.. PubMed. 111(3). 260–3. 19 indexed citations
19.
Carter, William B., Margaret A. McKenna, Mona L. Martin, & Elena M. Andresen. (1989). Health education: Special issues for older adults. Patient Education and Counseling. 13(2). 117–131. 19 indexed citations
20.
Armengaud, M., et al.. (1961). 2-Dehydro-Emetine in the Treatment of Amoebiasis.. Bulletin de la Société de pathologie exotique. 54(1). 29–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhardt Pohl Breakdown of academic impact, for papers by Erkki Kujansuu Breakdown of academic impact, for papers by Michael Schembri Breakdown of academic impact, for papers by Julie Krop Breakdown of academic impact, for papers by Anne M. Suskind Breakdown of academic impact, for papers by Stergios K. Doumouchtsis Breakdown of academic impact, for papers by Julie Birt Breakdown of academic impact, for papers by Marijke Van Kampen Breakdown of academic impact, for papers by Karen J. Carlson Breakdown of academic impact, for papers by Jemma Hudson
Rankless by CCL
2026